IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage plasmodium chabaudi malaria

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5160-5169

  Da Silva, Henrique Borges ^a   De Salles, Érika Machado ^a   Panatieri, Raquel Hoffmann ^a   Boscardin, Silvia Beatriz ^a   Rodríguez Málaga, Sérgio Marcelo ^a   Álvarez, José Maria ^a   Lima, Maria Regina D'Império ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITEMIA; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BLOOD; C57BL MOUSE; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; MALARIA; METABOLISM; PARASITOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LYMPHOCYTE COUNT; MALARIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PARASITEMIA; PLASMODIUM CHABAUDI; SIGNAL TRANSDUCTION;

EID: 84887464703     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300462     Document Type: Article

References (47)

1. World Health Organization. 2011. World Malaria Report. World Health Organization, Geneva, Switzerland.
2. Hafalla, J. C., O. Silvie, and K. Matuschewski. 2011. Cell biology and immunology of malaria. Immunol. Rev. 240:297-316.
3. Doolan, D. L., C. Dobaño, and J. K. Baird. 2009. Acquired immunity to malaria. Clin. Microbiol. Rev. 22:13-36.
4. Douradinha, B., and D. L. Doolan. 2011. Harnessing immune responses against Plasmodium for rational vaccine design. Trends Parasitol. 27:274-283.
5. Stephens, R., R. L. Culleton, and T. J. Lamb. 2012. The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol. 28:73-82.
6. Jarra, W., and K. N. Brown. 1985. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P.berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection. Parasite Immunol. 7:595-606.
7. Cheesman, S., A. Raza, and R. Carter. 2006. Mixed strain infections and strainspecific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice. Infect. Immun. 74:2996-3001.
8. McKenzie, F. E., D. L. Smith, W. P. O'Meara, and E. M. Riley. 2008. Strain theory of malaria: the first 50 years. Adv. Parasitol. 66:1-46.
9. Pattaradilokrat, S., S. J. Cheesman, and R. Carter. 2007. Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria. PLoS One 2:e857.
10. Cheesman, S., E. O'Mahony, S. Pattaradilokrat, K. Degnan, S. Knott, and R. Carter. 2010. A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I. Int. J. Parasitol. 40:951-961.
11. Hughes, A. L. 1992. Positive selection and interallelic recombination at the merozoite surface antigen-1 (MSA-1) locus of Plasmodium falciparum. Mol. Biol. Evol. 9:381-393.
12. Achtman, A. H., R. Stephens, E. T. Cadman, V. Harrison, and J. Langhorne. 2007. Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi. Parasite Immunol. 29:435-444.
13. Elliott, S. R., R. D. Kuns, and M. F. Good. 2005. Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect. Immun. 73:2478-2485.
14. Langhorne, J., F. M. Ndungu, A. M. Sponaas, and K. Marsh. 2008. Immunity to malaria: more questions than answers. Nat. Immunol. 9:725-732.
15. Freitas Do Rosário, A. P., S. M. Muxel, S. M. Rodríguez- Málaga, L. R. Sardinha, C. A. Zago, S. I. Castillo-Méndez, J. M. Álvarez, and M. R. D'Império Lima. 2008. Gradual decline in malaria-specific memory T cell responses leads to failure to maintain long-term protective immunity to Plasmodium chabaudi AS despite persistence of B cell memory and circulating antibody. J. Immunol. 181:8344-8355.
16. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593-1598.
17. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNg and TLR signaling pathways in macrophages. Immunobiology 211:511-524.
18. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226:41-56.
19. Franklin, B. S., P. Parroche, M. A. Ataíde, F. Lauw, C. Ropert, R. B. De Oliveira, D. Pereira, M. S. Tada, P. Nogueira, L. H. Da Silva, et al. 2009. Malaria primes the innate immune response due to interferon-γ induced enhancement of Tolllike receptor expression and function. Proc. Natl. Acad. Sci. USA 106:5789-5794.
20. Podoba, J. E., and M. M. Stevenson. 1991. CD4+ and CD8 + T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect. Immun. 59:51-58.
21. Garcia, C. R., M. F. De Azevedo, G. Wunderlich, A. Budu, J. A. Young, and L. Bannister. 2008. Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. Int Rev Cell Mol Biol 266:85-156.
22. Jiménez-Díaz, M. B., T. Mulet, V. Gómez, S. Viera, A. Alvarez, H. Garuti, Y. Vázquez, A. Fernández, J. Ibáñez, M. Jiménez, et al. 2009. Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Cytometry A 75:225-235.
23. Rottman, M., C. Soudais, G. Vogt, L. Renia, J. F. Emile, H. Decaluwe, J. L. Gaillard, and J. L. Casanova. 2008. IFN-γ mediates the rejection of haematopoietic stem cells in IFN-γR1-deficient hosts. PLoS Med. 5:e26.
24. Chomczynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-534, 536-537.
25. Kole, L., L. Das, and P. K. Das. 1999. Synergistic effect of interferon-γ and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis. J. Infect. Dis. 180:811-820.
26. Stephens, R., and J. Langhorne. 2010. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog. 6:e1001208.
27. Seixas, E., J. F. Moura Nunes, I. Matos, and A. Coutinho. 2009. The interaction between DC and Plasmodium berghei/chabaudi-infected erythrocytes in mice involves direct cell-to-cell contact, internalization and TLR. Eur. J. Immunol. 39:1850-1863.
28. Voisine, C., B. Mastelic, A. M. Sponaas, and J. Langhorne. 2010. Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int. J. Parasitol. 40:711-719.
29. Strutt, T. M., K. K. McKinstry, J. P. Dibble, C. Winchell, Y. Kuang, J. D. Curtis, G. Huston, R. W. Dutton, and S. L. Swain. 2010. Memory CD4 + T cells induce innate responses independently of pathogen. Nat. Med. 16:558-564, 1p, 564.
30. Muxel, S. M., A. P. Freitas Do Rosário, C. A. Zago, S. I. Castillo-Méndez, L. R. Sardinha, S. M. Rodriguez-Málaga, N. O. Câmara, J. M. Álvarez, and M. R. Lima. 2011. The spleen CD4 + T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties. PLoS One 6:e22434.
31. Naik, R. S., O. H. Branch, A. S. Woods, M. Vijaykumar, D. J. Perkins, B. L. Nahlen, A. A. Lal, R. J. Cotter, C. E. Costello, C. F. Ockenhouse, et al. 2000. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192:1563-1576.
32. Krishnegowda, G., A. M. Hajjar, J. Z. Zhu, E. J. Douglass, S. Uematsu, S. Akira, A. S. Woods, and D. C. Gowda. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280:8606-8616.
33. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104:1919-1924.
34. Doyle, S. E., R. M. O'Connell, G. A. Miranda, S. A. Vaidya, E. K. Chow, P. T. Liu, S. Suzuki, N. Suzuki, R. L. Modlin, W. C. Yeh, et al. 2004. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199:81-90.
35. Deng, T., X. Feng, P. Liu, K. Yan, Y. Chen, and D. Han. 2013. Toll-like receptor 3 activation differentially regulates phagocytosis of bacteria and apoptotic neutrophils by mouse peritoneal macrophages. Immunol. Cell Biol. 91:52-59.
36. Serghides, L., T. G. Smith, S. N. Patel, and K. C. Kain. 2003. CD36 and malaria: friends or foes? Trends Parasitol. 19:461-469.
37. Stevenson, M. M., and E. M. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169-180.
38. Favorite, G. O., and H. R. Morgan. 1942. Effects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella typhosa: clinical, hematological, chemical and serological tudies. J. Clin. Invest. 21:589-599.
39. Miller, S. I., R. K. Ernst, and M. W. Bader. 2005. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3:36-46.
40. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14.
41. Gatton, M. L., and Q. Cheng. 2002. Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals. Am. J. Trop. Med. Hyg. 66:467-473.
42. Boutlis, C. S., T. W. Yeo, and N. M. Anstey. 2006. Malaria tolerance-for whom the cell tolls? Trends Parasitol. 22:371-377.
43. Freitas Do Rosário, A. P., T. Lamb, P. Spence, R. Stephens, A. Lang, A. Roers, W. Muller, A. O'Garra, and J. Langhorne. 2012. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188:1178-1190.
44. McKinstry, K. K., T. M. Strutt, and S. L. Swain. 2010. The potential of CD4 T-cell memory. Immunology 130:1-9.
45. Taylor, J. J., and M. K. Jenkins. 2011. CD4+ memory T cell survival. Curr. Opin. Immunol. 23:319-323.
46. Artavanis-Tsakonas, K., J. E. Tongren, and E. M. Riley. 2003. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin. Exp. Immunol. 133:145-152.
47. Franklin, B. S., S. O. Rodrigues, L. R. Antonelli, R. V. Oliveira, A. M. Gonçalves, P. A. Sales-Junior, E. P. Valente, J. I. Alvarez-Leite, C. Ropert, D. T. Golenbock, and R. T. Gazzinelli. 2007. MyD88-dependent activation of dendritic cells and CD4+ T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect. 9:881-890.